- Market Capitalization, $K 146,196
- Shares Outstanding, K 37,200
- Annual Sales, $ 23,850 K
- Annual Income, $ -44,840 K
- 60-Month Beta 1.87
- Price/Sales 6.30
- Price/Cash Flow N/A
- Price/Book 5.94
|Period||Period Low||Period High||Performance|
| || |
-0.69 (-15.90%)since 06/23/21
| || |
-1.86 (-33.76%)since 04/23/21
| || |
-0.87 (-19.25%)since 07/23/20
/PRNewswire/ -- (NASDAQ: CLXT) will hold a conference call on at to discuss its results for the second quarter ended on . A press release detailing these results will be issued prior to the call.
/PRNewswire/ -- (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of as President and Chief Executive Officer, effective . Mr. Carr will also serve as a member...
Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics
(NASDAQ:CLXT), a plant-based technology company, today announced financial results for its first quarter ended March 31, 2021.
Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the MarketR&D Advancement with Complex Plant...
Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending...
Clorox (CLX) witnesses manufacturing and logistics costs. These along with higher selling and administrative costs might have hurt the bottom line in third-quarter fiscal 2021.
ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2021: